drugset / Trial / NCT04045847
CD147-CART Cells in Patients With Recurrent Malignant Glioma.
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, single-arm, open label and dose escalation clinical study of anti-CD147 CART cells in patients with recurrent malignant glioma.
Timeline
- Start
- 2019-05-30
- Primary completion
- 2020-10-30
- Completion
- 2022-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD147-CART | Cell therapy | — | Other |